Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

In 15 seconds, new test will ID presence of 25 most common mutations of cystic fibrosis

21.07.2003


"Eighty percent of all babies born in the US that have cystic fibrosis (CF) are born to parents with no previous family history." This attention-getting quote, used frequently by an activist in the CF community, makes it powerfully clear what few people realize: that both parents did not know they would pass on to their child the life-altering CFTR gene, the gene mutated in cystic fibrosis.



In fact, the Cystic Fibrosis Foundation estimates that more than 10 million Americans are unknowing, asymptomatic carriers of CF, which causes a thickening mucous to surround the lungs and serves as a catalyst for multiple, life-threatening infections throughout a lifetime.

Background


Approximately 30,000 children and adults in the US suffer from CF. In the Caucasian population, where it is most prevalent, one in 30 white Americans carry the mutated gene in their genome but do not manifest the disease. When one carrier with a certain disease allele mates with another who carries the identical disease allele, a process of recombination produces an offspring with the double mutation necessary to cause the disease. One in 3,000 live births has CF today.

CF has more than 1,000 currently known mutations and additional mutations are being discovered regularly. Most of the mutations are "private," running only in families and not outside a specific group. When the mutations exist within the family, many members will have it, the reason why so few common mutations exist.

The American College of Obstetrics and Gynecology (ACOG), American College of Medical Geneticists (ACMG) and National Institutes of Health (NIH) last year recommended that all individuals considering conception be screened for the presence of a mutated CF gene. The group examined all known mutations and identified those most prevalent for each ethnic group, and have recommended screening for the 25 which are most likely to occur (the "ACOG 25"). Each of the 25 mutations has also been ranked according to a disease severity index. For example, the severity of R117H, a rare ACOG 25 CF mutation, is associated with the presence of 5T, a variation on another region of the CF gene. Test results often show this 5T variation alone. Such results may be misleading for physicians and patients because this particular variant is not indicative of CF unless associated with the rare mutation (R117H) detected in the ACOG panel. Therefore, a reflex panel has been recommended to test for this particular variation only in the presence of the mutation.

The ACOG guidelines require that the female’s genotype be evaluated first. In the event her DNA reveals she has a CF mutation, a genetic counselor will explain the severity of CF any offspring would have, should an identical mutation be found in the male. When both parties have the same mutation, the odds are one-in-four that the offspring will be CF-positive.

Genetic Testing for Cystic Fibrosis

To discuss the current state of CF testing technology is Cindy WalkerPeach, Ph.D, of Ambion Diagnostics, a division of Ambion, Inc. in Austin, TX. Dr. WalkerPeach will make her presentation entitled, "Cystic Fibrosis Testing: Current Platforms and Emerging Technologies," during the 55th Annual Meeting of the American Association for Clinical Chemistry (AACC) in Philadelphia, PA, July 20-24, 2003.

The demand for testing has risen in the past year in response to the ACOG recommendations. Several manufacturers have developed screening tests to meet the increasing needs. Others are working on a newer generation of tests, classified as emerging technologies. Large laboratories have also conducted their own research and created in-house tests.

A New 15 Second Test

Ambion Diagnostics has developed a bead-array test that will become available in first quarter, 2004. The DNA test panel evaluates 31 CF mutations, including the 25 recommended for carrier screening by ACOG and ACMG. The test is divided into 2 parts, one for the ACOG 25 and if required, a separate reflex panel is performed to confirm the severity of detected mutation(s).

The bead-array test requires only that genomic DNA be taken from the patient, usually through a blood draw. Following the blood draw, the genomic DNA is isolated and single-tube PCR amplification of the genomic DNA is performed against the 31 different mutations. In one single reaction, the PCR products are hybridized to probes tethered onto small color-coded microspheres. Each microsphere is run through a laser beam that identifies the presence of a mutation. After hybridization, all ACOG 25 mutations are screened in 15 seconds.

A benefit of this test is allowing laboratories to run thousands of tests each week. With the dramatic increase in the desire for testing, following the ACOG recommendations, labs are experiencing delays in conducting their current tests and sending results to physicians. Another benefit of this test is that it can be easily expanded to test for selected CF mutations not included in the ACOG 25.

Conclusions

By knowing the family-specific mutations, other family members could be tested to identify CF carriers. However, since so many rare mutations have been described, not all mutations will be detected by the screening test. If the history or specific mutation is not known, a negative screening test will reduce, but not eliminate, the risk of being a carrier. The new test will allow potential parents to know more quickly if they are carriers of any of the ACOG 25 CF mutations. The hope is that for parents-to-be, such knowledge will not only help them to make more informed decisions, but also allow for treatment options that can greatly impact quality of life.

Donna Krupa | EurekAlert!
Further information:
http://www.aacc.org

More articles from Health and Medicine:

nachricht NIST scientists discover how to switch liver cancer cell growth from 2-D to 3-D structures
17.11.2017 | National Institute of Standards and Technology (NIST)

nachricht High speed video recording precisely measures blood cell velocity
15.11.2017 | ITMO University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

Im Focus: Researchers Develop Data Bus for Quantum Computer

The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.

Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...

Im Focus: Wrinkles give heat a jolt in pillared graphene

Rice University researchers test 3-D carbon nanostructures' thermal transport abilities

Pillared graphene would transfer heat better if the theoretical material had a few asymmetric junctions that caused wrinkles, according to Rice University...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

NASA detects solar flare pulses at Sun and Earth

17.11.2017 | Physics and Astronomy

NIST scientists discover how to switch liver cancer cell growth from 2-D to 3-D structures

17.11.2017 | Health and Medicine

The importance of biodiversity in forests could increase due to climate change

17.11.2017 | Studies and Analyses

VideoLinks
B2B-VideoLinks
More VideoLinks >>>